Le Lézard
Classified in: Health, Business
Subjects: MAV, JVN, MAT

Media Advisory - PS Bill Blair to make an announcement about research into cannabis use


TORONTO, Jan. 23, 2018 /CNW/ - Bill Blair, the Parliamentary Secretary to the Minister of Justice and Attorney General of Canada and to the Minister of Health, will be visiting the Centre for Addiction and Mental Health (CAMH) to tour their facilities and highlight important research into cannabis use. He'll be joined by Dr. Samuel Weiss, Scientific Director of CIHR's Institute of Neurosciences, Mental Health and Addiction.

Date:

January 24, 2018                                



Time:             

11:00 A.M. EST        



Location:

Center for Addiction and Mental Health, 33 Russell St., Toronto

           

SOURCE Centre for Addiction and Mental Health


These press releases may also interest you

at 09:00
Known for Affordable Oral Health Care, Dental Care Acworth is Offering a New High-Tech AI Dental Patient Experience
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Top Dentist, Dr. Conrad Ma, Joins Tolland Hill Family Dental in Tolland, Connecticut
Tolland Hill Family Dental is thrilled to announce the addition of Dr. Conway Ma to its esteemed team of dental professionals. Tolland Hill Family Dental offers a wide range of services, catering to patients of all ages. From a child's first dental...

at 09:00
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

at 09:00
Novel T-cell engager, CDH17 X CD3 cabotamig (ARB202) continues to explore dosing in patients with advanced gastrointestinal cancers
Arbele, a clinical-stage biotechnology company focused...

at 08:53
Growing Wilmington-Based Alera Health Named a Great Employer in North Carolina
Alera Health, a leader in population health management integrating behavioral healthcare, is proud to announce its recognition as one of the Great Employers to Work for in North Carolina by Best Companies Group. The 2024 Great Employers to Work for...

More news about Health...


News published on and distributed by: